Exhibit 99.41
![]() |
5251 Duke St., Suite 400 | Tel: | 902-424-7059 | |
Duke Tower | Fax: | 902-424-4625 | ||
Securities | P.O. Box 458 | Website: nssc.novascotia.ca | ||
Commission | Halifax, Nova Scotia | |||
B3J 2P8 |
RECEIPT
Immunovaccine Inc.
This is the receipt of the Nova Scotia Securities Commission for the Short Form Prospectus of the above Issuer dated June 15, 2017 (the Prospectus).
This receipt also evidences that the Ontario Securities Commission has issued a receipt for the Prospectus.
The Prospectus has been filed under Multilateral Instrument 11-102 Passport System in British Columbia, Alberta, Saskatchewan, Manitoba, Quebec and Newfoundland and Labrador. A receipt for the Prospectus is deemed to be issued by the regulator in each of those jurisdictions, if the conditions of the Instrument have been satisfied.
June 16, 2017
(Signed) “Abel Lazarus” | |
Abel Lazarus | |
Acting Director of Corporate Finance | |
SEDAR Project #2637829 |